Search results
Results from the WOW.Com Content Network
Necrotizing pneumonia (NP), also known as cavitary pneumonia or cavitatory necrosis, is a rare but severe complication of lung parenchymal infection. [ 1 ] [ 2 ] [ 3 ] In necrotizing pneumonia, there is a substantial liquefaction following death of the lung tissue, which may lead to gangrene formation in the lung.
With pneumonic plague, the first signs of illness are fever, headache, weakness and rapidly developing pneumonia with shortness of breath, chest pain, cough and sometimes bloody or watery sputum. [6] The pneumonia progresses for two to four days and may cause respiratory failure and shock. Patients will die without early treatment, some within ...
Person-years of potential life lost in the United States in 2006 [8] Cause of premature death Person-years lost Cancer: 8.6 million Heart disease and strokes: 8.8 million Accidents and other injuries: 5.9 million All other causes: 13.6 million
Pneumonia is a common respiratory infection, [2] affecting approximately 450 million people a year and occurring in all parts of the world. [3] It is a major cause of death among all age groups, resulting in 1.4 million deaths in 2010 (7% of the world's yearly total) and 3.0 million deaths in 2016 (the 4th leading cause of death in the world).
Pneumonia believed to be due to bacteria is treated with antibiotics. [11] If the pneumonia is severe, the affected person is generally hospitalized. [20] Oxygen therapy may be used if oxygen levels are low. [11] Each year, pneumonia affects about 450 million people globally (7% of the population) and results in about 4 million deaths.
Pneumococcal pneumonia kills about 1 in 20 older adults infected with the bacteria, according to the CDC. Roughly 100 known strains of pneumococcus bacteria can also cause ear infections ...
It is the most common bacterial pneumonia found in adults, the most common type of community-acquired pneumonia, and one of the common types of pneumococcal infection. The estimated number of Americans with pneumococcal pneumonia is 900,000 annually, with almost 400,000 cases hospitalized and fatalities accounting for 5-7% of these cases. [2]
Despite high levels of gross research funding, lung cancer funding per death lags behind many other cancers, with around $3,200 spent on lung cancer research in 2022 per US death, considerably lower than that for brain cancer ($22,000 per death), breast cancer ($14,000 per death), and cancer as a whole ($11,000 per death). [118]